Questions: Microbiome-Immune Interactions and Mucosal Homeostasis

Question 1

A patient receives broad-spectrum antibiotics for a severe infection. Six months later, they develop inflammatory bowel disease. Based on the microbiome-immune homeostasis framework, which sequence of events best explains this outcome?

• A. Antibiotics directly activated inflammatory cytokine production, which persisted and caused mucosal damage
• B. Antibiotics killed pathogens that were suppressing the immune system, releasing previously inhibited inflammatory responses
• C. Antibiotics disrupted commensal diversity, reducing Treg-promoting species, weakening barrier integrity, and allowing bacterial products to translocate and trigger chronic inflammation
• D. Antibiotics depleted IgA, enabling opportunistic pathogens to colonize the gut and directly damage the mucosa

Answer: (C)

The causal chain runs through dysbiosis: antibiotic-induced loss of microbial diversity preferentially depletes commensal species (like certain Clostridia) that drive regulatory T cell differentiation. Without adequate Treg induction, the tolerogenic signals that suppress inflammatory responses to commensal antigens weaken. Simultaneously, barrier-supporting species are lost, reducing IgA coating efficiency and IL-22-driven epithelial tightness. Bacterial products (LPS, peptidoglycans) translocate across the leaky barrier, activating pattern recognition receptors and triggering the chronic mucosal inflammation characteristic of IBD. Option D has a factual element (antibiotics affect IgA-producing B cells indirectly) but is not the primary mechanism.

Question 2

What is the primary immunological function of secretory IgA at mucosal surfaces in the context of microbiome homeostasis?

• A. Opsonizing and killing commensal bacteria to prevent overgrowth
• B. Activating the complement cascade against pathobionts that breach the epithelium
• C. Coating commensal bacteria to confine them to the intestinal lumen and prevent epithelial contact — immune exclusion
• D. Presenting commensal antigens to dendritic cells to promote Th17 differentiation

Answer: (C)

Secretory IgA functions primarily through immune exclusion — it coats commensal bacteria, preventing them from adhering to and penetrating the epithelial surface. IgA does not opsonize for killing (that is IgG's role); instead it 'packages' bacteria in the lumen, maintaining spatial segregation between the massive commensal load and the underlying host tissue. This is an active, immune-mediated mechanism for tolerating rather than eliminating commensals: the gut produces 3–5 grams of IgA daily, specifically to maintain this boundary. Complement activation (option B) would be destructive and is not the primary mucosal mechanism here. IgA promotes commensal tolerance, not Th17 induction.

Question 3

Specific commensal bacteria actively drive regulatory T cell differentiation, directly contributing to immune tolerance at mucosal surfaces.

• T. True
• F. False

Answer: True

This is the key insight distinguishing the active education model from a passive tolerance model. Bacteria like Clostridia clusters IV and XIVa and Bacteroides fragilis (via its polysaccharide A) do not merely fail to trigger immunity — they actively induce Treg differentiation by stimulating the production of tolerogenic signals including IL-10, TGF-β, and retinoic acid from dendritic cells and epithelial cells. Germ-free animals have markedly fewer intestinal Tregs, and colonization with specific commensal species restores them. The microbiome is not a passive passenger in immune education; specific taxa actively shape immune cell fate decisions.

Question 4

The microbiome is a component of the immune system that has co-evolved with host immune cells to coordinate mucosal defense.

• T. True
• F. False

Answer: False

The microbiome is a distinct ecosystem — a community of living organisms with their own evolutionary interests — that the immune system has evolved to manage. Describing it as 'part of the immune system' blurs this distinction in a way that leads to incorrect predictions: for example, it would imply that depleting the microbiome weakens immunity uniformly, when in fact dysbiosis can impair some immune functions (tolerance, barrier integrity) while transiently altering others. The immune system and the microbiome are in a bidirectional, mutually shaping relationship, but they are separate systems with different identities. The microbiome educates the immune system; it is not itself an immune component.

Question 5

Explain the bidirectional relationship between the microbiome and the immune system, and why disruption of this relationship through dysbiosis can promote autoimmune or inflammatory disease.

Model answer: The relationship is bidirectional: the microbiome shapes the immune system, and the immune system shapes the microbiome. Commensals actively promote tolerogenic immune states by inducing Treg differentiation (via Clostridia, B. fragilis PSA) and stimulating IL-22 production from ILC3s, which maintains epithelial barrier integrity and antimicrobial peptide production. Simultaneously, the immune system confines and controls the microbiome through secretory IgA (immune exclusion), antimicrobial peptides, and the mucus layer, preventing commensals from breaching the epithelium. Dysbiosis — loss of commensal diversity, often from antibiotics or dietary changes — depletes Treg-inducing species, weakening the tolerogenic signals. Barrier function deteriorates, allowing bacterial products to translocate across the epithelium and activate pattern recognition receptors in the lamina propria. The resulting inflammatory signals can drive sustained mucosal inflammation (IBD) or, by disrupting peripheral tolerance more broadly, contribute to systemic autoimmunity. The therapeutic implication is restoring specific beneficial commensals to re-establish the tolerogenic education.

The key to this answer is demonstrating the bidirectionality — not just one direction — and connecting the mechanism (lost Treg induction + barrier failure + LPS translocation) to the pathological outcome. Students who describe it as one-way (microbiome trains immunity, or immunity controls microbiome) miss the co-regulatory nature of the relationship that makes dysbiosis particularly destabilizing.